http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021251394-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_68c549c0585d20694ff9630fad2aa972
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2500-95
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2501-415
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2501-11
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2500-32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2506-45
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L27-3839
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L27-3873
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L27-38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-0657
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L27-3804
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L27-3826
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L27-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L27-38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-077
filingDate 2021-06-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_58ca2f81a84fe77583ae4549b5182313
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ac2fe104b0097e5d47a2aa114976dc6a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_34f409447252606996bc40232402add9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_700f586652d82798254f94dfd6f87bab
publicationDate 2021-12-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2021251394-A1
titleOfInvention Method for producing cardiomyocyte population with improved cardiomyocyte purity, method for purifying cardiomyocytes, cardiomyocyte population, and graft material
abstract A method for producing a cardiomyocyte population having improved cardiomyocyte purity, wherein a cell population comprising cardiomyocytes is cultured in a culturing solution containing a WNT signal activator and an EGF receptor inhibitor, and the purity of the cardiomyocytes in the cell population is improved.
priorityDate 2020-06-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2014136519-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2015119575-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2015182765-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3081361
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226400071
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID176870
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID208908
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5281222
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399366
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226506472
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399616

Total number of triples: 37.